Antimicrobial resistance: progress in the decade since emergence of New Delhi metallo-β-lactamase in India A Dixit, N Kumar, S Kumar, V Trigun Indian journal of community medicine 44 (1), 4-8, 2019 | 126 | 2019 |
“Frustrated,”“depressed,” and “devastated” pediatric trainees: US academic medical centers fail to provide adequate workplace breastfeeding support A Dixit, L Feldman-Winter, KA Szucs Journal of Human Lactation 31 (2), 240-248, 2015 | 86 | 2015 |
Complete heart block, severe ventricular dysfunction, and myocardial inflammation in a child with COVID-19 infection I El-Assaad, MI Hood-Pishchany, J Kheir, K Mistry, A Dixit, O Halyabar, ... Case Reports 2 (9), 1351-1355, 2020 | 54 | 2020 |
Severe acute respiratory syndrome coronavirus 2 infection in febrile neonates H Wardell, JI Campbell, C VanderPluym, A Dixit Journal of the Pediatric Infectious Diseases Society 9 (5), 630-635, 2020 | 53 | 2020 |
Globally diverse Mycobacterium tuberculosis resistance acquisition: a retrospective geographical and temporal analysis of whole genome sequences Y Ektefaie, A Dixit, L Freschi, MR Farhat The Lancet Microbe 2 (3), e96-e104, 2021 | 39 | 2021 |
Whole genome sequencing identifies bacterial factors affecting transmission of multidrug-resistant tuberculosis in a high-prevalence setting A Dixit, L Freschi, R Vargas, R Calderon, J Sacchettini, F Drobniewski, ... Scientific Reports 9 (1), 5602, 2019 | 38 | 2019 |
GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning MI Gröschel, M Owens, L Freschi, R Vargas, MG Marin, J Phelan, Z Iqbal, ... Genome medicine 13, 1-14, 2021 | 32 | 2021 |
Parental leave policies and pediatric trainees in the United States A Dixit, L Feldman-Winter, KA Szucs Journal of Human Lactation 31 (3), 434-439, 2015 | 27 | 2015 |
Use of generic medicines: Challenges and benefits A Dixit, N Kumar, S Kumar Journal of health management 20 (1), 84-90, 2018 | 21 | 2018 |
A systematic review of nutritional supplementation in HIV-infected children in resource-limited settings MS McHenry, A Dixit, RC Vreeman Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2015 | 21 | 2015 |
Mycoplasma hominis Empyema in an 18-Year-old Stem Cell and Lung Transplant Recipient: Case Report and Review of the Literature A Dixit, S Alexandrescu, D Boyer, EH Graf, SO Vargas, M Silverman J Pediatric Infect Dis Soc, 2017 | 18 | 2017 |
Safety and tolerability of moxifloxacin in children A Dixit, MV Karandikar, S Jones, MM Nakamura Journal of the Pediatric Infectious Diseases Society 7 (3), e92-e101, 2018 | 17 | 2018 |
Exploring healthcare perspectives of Burmese Chin refugees. MS McHenry, R Umoren, A Dixit, R Holliday, D Litzelman Journal of Cultural Diversity 23 (4), 2016 | 15 | 2016 |
Tuberculosis pathways to care and transmission of multidrug resistance in India SR Atre, JD Jagtap, MI Faqih, YK Dumbare, TU Sawant, SL Ambike, ... American journal of respiratory and critical care medicine 205 (2), 233-241, 2022 | 12 | 2022 |
Adolescent Burmese refugees perspectives on determinants of health A Dixit, EM Miner, SE Wiehe, MS McHenry Journal of Immigrant and Minority Health 20, 370-379, 2018 | 8 | 2018 |
Associations of immunogenicity and reactogenicity after SARS-CoV-2 mRNA-1273 vaccine in COVE and TeenCOVE trials U Siangphoe, LR Baden, HM El Sahly, B Essink, K Ali, G Berman, ... Clin Infect Dis, 2022 | 4* | 2022 |
Estimation of country-specific tuberculosis antibiograms using genomic data A Dixit, L Freschi, R Vargas Jr, MI Groeschel, S Tahseen, SMM Alam, ... medRxiv, 2021.09. 23.21263991, 2021 | 2 | 2021 |
Tuberculosis resistance acquisition in space and time: an analysis of globally diverse M. tuberculosis whole genome sequences Y Ektefaie, A Dixit, L Freschi, M Farhat bioRxiv, 837096, 2019 | 2 | 2019 |
Interim safety and immunogenicity of COVID-19 omicron BA. 1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial A Dixit, R Bennett, K Ali, C Griffin, RA Clifford, M Turner, R Poston, ... The Lancet Infectious Diseases, 2024 | 1 | 2024 |
1939. Who to Boost When: An Analysis of Dosing Interval and Age on COVID-19 Outcomes in the COVE Trial During the Delta and Omicron Waves D Follmann, X Wang, P Gilbert, LR Baden, HM El Sahly, B Essink, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 2470, 2023 | 1 | 2023 |